Shopping Cart 0
Cart Subtotal
USD 0

Global Plasma Protease C1-inhibitor Treatment Market Study 2015-2025, by Segment (C1-inhibitors, Kallikrein Inhibitor (Kalbitor), Selective Bradykinin B2 Receptor Antagonist (Firazyr)), by Market (Hospital Pharmacies, Independent Pharmacies and Outlets), by Company (Shire plc, CSL Limited, Sanquin)

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 1800

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 2000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 3600

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 3600
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

The global Plasma Protease C1-inhibitor Treatment market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

By Drug Class

C1-inhibitors

Kallikrein Inhibitor (Kalbitor)

Selective Bradykinin B2 Receptor Antagonist (Firazyr)

By Dosage Type

Liquid/Injectable

Lyophilized

Demand Coverage (Market Size & Forecast, Consumer Distribution):

Hospital Pharmacies

Independent Pharmacies and Outlets

Company Coverage (Sales data, Main Products & Services etc.):

Shire plc

CSL Limited

Sanquin

Pharming Group N.V.

Major Region Market

North America

Europe

Asia-Pacific

South America

Middle East & Africa

READ MORE

Table Of Content

Scope

Table of Content

1 Industry Overview

1.1 Plasma Protease C1-inhibitor Treatment Industry

1.1.1 Overview

1.1.2 Products of Major Companies

1.2 Market Segment

1.2.1 Industry Chain

1.2.2 Consumer Distribution

1.3 Price & Cost Overview

2 Plasma Protease C1-inhibitor Treatment Market by Type

2.1 By Drug Class

2.1.1 C1-inhibitors

2.1.2 Kallikrein Inhibitor (Kalbitor)

2.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)

2.2 By Dosage Type

2.2.1 Liquid/Injectable

2.2.2 Lyophilized

2.3 Market Size by Type

2.4 Market Forecast by Type

3 Global Market Demand

3.1 Segment Overview

3.1.1 Hospital Pharmacies

3.1.2 Independent Pharmacies and Outlets

3.2 Market Size by Demand

3.3 Market Forecast by Demand

4 Major Region Market

4.1 Global Market Overview

4.1.1 Market Size & Growth

4.1.2 Market Forecast

4.2 Major Region

4.2.1 Market Size & Growth

4.2.2 Market Forecast

5 Major Companies List

5.1 Shire plc (Company Profile, Sales Data etc.)

5.2 CSL Limited (Company Profile, Sales Data etc.)

5.3 Sanquin (Company Profile, Sales Data etc.)

5.4 Pharming Group N.V. (Company Profile, Sales Data etc.)

6 Conclusion


List Of Figure

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in USD Million

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in Volume

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in USD Million

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in Volume


List Of Table

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Drug Class, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Drug Class, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in Volume

Table Shire plc Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CSL Limited Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanquin Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pharming Group N.V. Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Snapshot

The global Plasma Protease C1-inhibitor Treatment market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

By Drug Class

C1-inhibitors

Kallikrein Inhibitor (Kalbitor)

Selective Bradykinin B2 Receptor Antagonist (Firazyr)

By Dosage Type

Liquid/Injectable

Lyophilized

Demand Coverage (Market Size & Forecast, Consumer Distribution):

Hospital Pharmacies

Independent Pharmacies and Outlets

Company Coverage (Sales data, Main Products & Services etc.):

Shire plc

CSL Limited

Sanquin

Pharming Group N.V.

Major Region Market

North America

Europe

Asia-Pacific

South America

Middle East & Africa

READ MORE

Scope

Table of Content

1 Industry Overview

1.1 Plasma Protease C1-inhibitor Treatment Industry

1.1.1 Overview

1.1.2 Products of Major Companies

1.2 Market Segment

1.2.1 Industry Chain

1.2.2 Consumer Distribution

1.3 Price & Cost Overview

2 Plasma Protease C1-inhibitor Treatment Market by Type

2.1 By Drug Class

2.1.1 C1-inhibitors

2.1.2 Kallikrein Inhibitor (Kalbitor)

2.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)

2.2 By Dosage Type

2.2.1 Liquid/Injectable

2.2.2 Lyophilized

2.3 Market Size by Type

2.4 Market Forecast by Type

3 Global Market Demand

3.1 Segment Overview

3.1.1 Hospital Pharmacies

3.1.2 Independent Pharmacies and Outlets

3.2 Market Size by Demand

3.3 Market Forecast by Demand

4 Major Region Market

4.1 Global Market Overview

4.1.1 Market Size & Growth

4.1.2 Market Forecast

4.2 Major Region

4.2.1 Market Size & Growth

4.2.2 Market Forecast

5 Major Companies List

5.1 Shire plc (Company Profile, Sales Data etc.)

5.2 CSL Limited (Company Profile, Sales Data etc.)

5.3 Sanquin (Company Profile, Sales Data etc.)

5.4 Pharming Group N.V. (Company Profile, Sales Data etc.)

6 Conclusion


List Of Figure

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in USD Million

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in Volume

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in USD Million

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in Volume


List Of Table

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Drug Class, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Drug Class, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in Volume

Table Shire plc Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CSL Limited Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanquin Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pharming Group N.V. Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com